Table 1.
Characteristics of 20 patients with advanced-stage classical Hodgkin lymphoma.
| Patients (n=20) | ||
|---|---|---|
| Sex (n, %) | ||
| Male | 6 (30.0) | |
| Female | 14 (70.0) | |
| Age at diagnosis (mean, range) | 33 (18-61) | |
| Disease subtype (n, %) | ||
| Nodular sclerosing | 14 (70.0) | |
| Mixed-cellularity | 4 (12.5) | |
| Lymphocyte-rich | 2 (10.0) | |
| Lymphocyte-depleted | 0 (0.0) | |
| Albumin, g/dL, (mean, range) | 3.9 (2.51-4.68) | |
| Hemoglobin, g/dL, (mean, range) | 12.9 (8.7-14.8) | |
| Lymphocytes, x103/uL, (mean, range) | 1.70 (0.5-3.3) | |
| Neutrophils, x103/uL, (mean, range) | 8.6 (2.7-18.8) | |
| Bulky mass (n, %) | 12 (60.0) | |
| B symptoms (n, %) | 19 (95.0) | |
| Extranodal extension (n, %) | 9 (45.0) | |
| IPS score ≥4 | 2 (10.0) | |
| Ann Arbor | ||
| Stage 2b (n, %) | 9 (45.0) | |
| Stage 3 (n, %) | 7 (35.0) | |
| Stage 4 (n, %) | 4 (12.5) | |